Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$188,619,917
-$211,777,914 QoQ
Shares Held
2,624,825
-22.5% QoQ
Ownership
0.635%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 1%
None 19%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188,619,917 | 2,624,825 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $400,397,831 | 3,387,174 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $281,396,044 | 2,236,497 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $381,583,092 | 2,607,867 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $400,900,344 | 2,570,698 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $442,294,512 | 2,686,271 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $348,141,971 | 2,136,758 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $569,833,378 | 2,916,539 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $460,729,675 | 2,657,647 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $446,012,677 | 2,635,853 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $469,372,889 | 2,378,137 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $403,483,275 | 2,319,136 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $373,652,812 | 2,169,751 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $189,875,575 | 1,140,805 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $219,751,279 | 1,499,497 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $311,133,618 | 2,098,143 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $397,200,137 | 2,310,781 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $296,852,158 | 1,574,061 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $311,080,163 | 1,274,762 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $233,083,119 | 1,200,593 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $307,432,308 | 1,649,669 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $219,080,501 | 1,391,164 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $225,358,700 | 1,361,684 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $205,700,097 | 1,243,878 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $149,766,625 | 1,092,868 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $130,159,368 | 1,105,951 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||